Company: HCWB
Filing Date: 2025-05-15
Form Type: 10-Q
Source: 0000950170-25-072833
Chunk: 9

Company: HCW Biologics Inc.
Filing Date: 2025-05-15
Form: 10-Q
Item: Item 1
Chunk 9
---
HCW Biologics Inc. 

Condensed Balance Sheets 

     December 31,

     March 31,

     2024

     2025

     Unaudited

     ASSETS

     Current assets:

     Cash and cash equivalents
      
     $
     4,674,572

     $
     1,107,613

     Accounts receivable, net

     582,201

     87,493

     Prepaid expenses

     328,181

     256,291

     Other current assets

     113,528

     443,311

     Total current assets

     5,698,482

     1,894,708

     Investments

     1,599,751

     1,599,751

     Property, plant and equipment, net

     22,909,869

     22,762,471

     Other assets

     28,476

     28,476

     Total assets
      
     $
     30,236,578

     $
     26,285,406

     LIABILITIES AND STOCKHOLDERS’ DEFICIT

     Liabilities

     Current liabilities:

     Accounts payable
      
     $
     22,332,261

     $
     19,734,057

     Accrued liabilities and other current liabilities

     981,940

     1,173,695

     Short-term debt, net

     6,314,684

     6,234,338

     Total current liabilities

     29,628,885

     27,142,090

     Debt, net

     7,377,865

     7,705,364

     Total liabilities

     37,006,750

     34,847,454

     Commitments and contingencies (Note 9)

     Stockholders’ deficit:

     Common stock:

     Common, $0.0001 par value; 250,000,000 shares authorized   and 44,541,295 shares issued at December 31, 2024; 250,000,000 shares    authorized and 44,934,120 shares issued at March 31, 2025

     4,454

     4,493

     Additional paid-in capital

     93,781,511